SEC Info - AbCellera Biologics Inc. - ‘S-8’ on 12/14/20

SEC Info℠

Home

Help

Please Sign In

AbCellera Biologics Inc. – ‘S-8’ on 12/14/20 – ‘EX-23.1’

On: Monday, 12/14/20, at 8:24pm ET · As of: 12/15/20 · Effective: 12/15/20 · Accession #: 1193125-20-317281 · File #: 333-251341

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/15/20  AbCellera Biologics Inc.          S-8        12/15/20    4:131K                                   Donnelley … Solutions/FA

Registration Statement – Securities for an Employee Benefit Plan — Form S-8 — SA’33
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-8         Registration Statement - Securities for an          HTML     58K 
                Employee Benefit Plan                                            
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     16K 
 3: EX-23.1     Consent of Expert or Counsel                        HTML      5K 
 4: EX-23.2     Consent of Expert or Counsel                        HTML      6K

‘EX-23.1’ — Consent of Expert or Counsel

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

AbCellera Biologics Inc.

We, KPMG LLP, consent to the use of our report, dated October 2, 2020, except for Note 18, as to which the date is December 7, 2020, with respect to the consolidated financial statements of AbCellera Biologics Inc. incorporated by reference herein. Our report refers to a change in the method of accounting for leases as of January 1, 2019 due to the adoption of Accounting Standards Codification Topic 842, Leases.

/s/ KPMG LLP

Chartered Professional Accountants

Vancouver, Canada

December 14, 2020

Dates Referenced Herein and Documents Incorporated by Reference

This ‘S-8’ Filing	Date	Other Filings

Filed as of / Effective on:	12/15/20	4
Filed on:	12/14/20	424B4
	12/7/20	S-1/A
	10/2/20	DRS
	1/1/19
		List all Filings

2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  AbCellera Biologics Inc.          S-8         2/20/24    4:882K
 2/21/23  AbCellera Biologics Inc.          S-8         2/21/23    4:88K                                    Donnelley … Solutions/FA

5 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/14/20  AbCellera Biologics Inc.          424B4                  1:6.5M                                   Donnelley … Solutions/FA
12/10/20  AbCellera Biologics Inc.          S-1/A                  4:6.6M                                   Donnelley … Solutions/FA
12/08/20  AbCellera Biologics Inc.          8-A12B                 1:14K                                    Donnelley … Solutions/FA
12/07/20  AbCellera Biologics Inc.          S-1/A                 19:9.3M                                   Donnelley … Solutions/FA
11/20/20  AbCellera Biologics Inc.          S-1                   15:8.3M                                   Donnelley … Solutions/FA

↑Top

Filing Submission 0001193125-20-317281 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)